Biotech—it's complicated. A successful product launch requires grit, determination, and clear direction. But let’s be real, the path to launch isn’t a straight one. There are curves, hard turns, and dead ends. Here’s the good news, you don’t have to navigate the complexities alone. Welcome to The Emerging Biotech Leader, where we help biotech leaders maximize the value of their therapeutics from clinical development to product launch.
…
continue reading
Biotech2050 Podcast is a think tank chronicling the disruptions changing the biotech industry over the next 50 years.
…
continue reading
Talking Biotech is a weekly podcast that uncovers the stories, ideas and research of people at the frontier of biology and engineering. Each episode explores how science and technology will transform agriculture, protect the environment, and feed 10 billion people by 2050. Interviews are led by Dr. Kevin Folta, a professor of molecular biology and genomics.
…
continue reading
This podcast aims to bring you a daily summary of the most relevant news in Pharma and BioTech. Check our website at: https://www.buzzsprout.com/2189790
…
continue reading
Welcome to The Biotech Startups Podcast by Excedr. Join us as we speak with first-time founders, experienced scientists, long-time company operators, serial entrepreneurs, and biotech investors about the challenges and triumphs of running a biotech startup. Gain actionable insight into navigating the ever-changing life sciences industry in each episode as we explore the business of science, from pre-seed to IPO. With your host, Jon Chee.
…
continue reading
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is p ...
…
continue reading
Inside Biotech is an exciting podcast from BCLA, which focuses on the science behind SoCal’s most innovative new biotech companies. This semi-monthly podcast, hosted by Gabriella Rubert, Ph.D. Candidate at UCLA and Podcast Lead at BCLA, is the perfect way for anyone interested in LA’s biotech community to stay informed about current progress and developments. Episodes feature conversations with scientists, entrepreneurs, investors, and more about the cutting-edge science that goes on inside ...
…
continue reading
Data in Biotech is a fortnightly podcast exploring how companies leverage data to drive innovation in life sciences. Every two weeks, Ross Katz, Principal and Data Science Lead at CorrDyn, sits down with an expert from the world of biotechnology to understand how they use data science to solve technical challenges, streamline operations, and further innovation in their business. You can learn more about CorrDyn - an enterprise data specialist that enables excellent companies to make smarter ...
…
continue reading
Welcome to the official Labiotech.eu podcast - Beyond Biotech! Each week, we talk about what's happening in the world of biotech, with news and interviews with experts from companies around the world. Join us as we cover the latest news, breakthroughs and innovations shaping the life sciences industry.A new podcast episode is available every Friday.The host is Jim Cornall.
…
continue reading
Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the work of others, BioTech Nation is the voice of human endeavor, driving science to new realities for ...
…
continue reading
Grow Everything reveals the world of biology as technology. Hosts Erum Khan and Karl Schmieder interview leaders and influencers biologizing industries with tools like synthetic biology, precision fermentation, bioprospecting, and more. These companies make biomaterials from waste, cosmetics that restore healthy hair and skin, and delicious cultivated foods in a bioreactor and so much more. Join us as we discuss the latest and greatest across biotech, synbio, entrepreneurship, and culture an ...
…
continue reading
1
Israeli Technology Founders Speak: Conversations with Successful Israeli Hitech and Biotech Entrepreneurs
JMB Davis Ben-David International IP Law Firm
Podcast by JMB Davis Ben-David International IP Law Firm
…
continue reading
In the Biotech Career Coach podcast, we share valuable insights and advice for job seekers and career-minded individuals in the biotechnology and life sciences industry. From resume tips to leadership strategies, this podcast will help you navigate your job search and succeed in your career. This podcast is a production of The Collaboratory Career Hub To join our Community or access great resources, visit www.library.collaboratorycareerhub.com
…
continue reading
From the ground floor to the C-Suite, Building Biotechs offers a behind-the-scenes look into the strategy that goes into launching and scaling successful biotech and life science companies. We talk with biotech executives, founders, HR leaders, and culture builders to learn how they think about growing companies with intention, and discuss the valuable lessons they’ve learned along the way.
…
continue reading
Welcome to the Biotech Bytes podcast, where we sit down with Biotech and Pharma IT leaders to learn what's working in our industry. Steven Swan is the CEO of The Swan Group LLC. He has 20 years of experience working with companies and individuals to make long-term matches. Focusing on Information technology within the Biotech and Pharmaceutical industries has allowed The Swan Group to become a valued partner to many companies. Staying in constant contact with the marketplace and its trends a ...
…
continue reading
In this podcast, entrepreneur and angel investor Flavio Rump discusses the biggest bottlenecks and the future of biotech by speaking with some of the sharpest, most innovative minds in biotechnology and related fields.
…
continue reading
A podcast to share the tools, tips, tricks and routines of the best biotech executives in the industry in order to help develop the next generation of biotech leaders and expedite the launch of new therapies and transform the lives of patients' all over the world.
…
continue reading
Forschungsthemen aus dem Bereich Biotechnologie und Verfahrenstechnik an der TUHH
…
continue reading
Biotech knowledge center
…
continue reading
Matt breaks down relevant biotech stocks, analyzing their data and determining if they are a good investment.
…
continue reading
BioTech Nation Radio with Dr Moira Gunn
…
continue reading
Interviews with innovators at the intersections of science, data, and technology.
…
continue reading
Welcome to the biotech podcast where we talk to the leading scientists in the world about their work, their lives and fundamental questions concerning their field.
…
continue reading
Defination Uses Various processes in Tissue - culture
…
continue reading
1
Smart Biotech Scientist | Master Bioprocess CMC Development, Biologics Manufacturing & Scale-up for Busy Scientists
David Brühlmann: Biotech Entrepreneur & Cell Culture Technology Innovation Aficionado
The Go-to Podcast for Biotech Scientists Who Want to Master Bioprocess CMC Development and Manufacturing of Biologics. **TOP 10 LIFE SCIENCES PODCAST** Do you want to simplify bioprocessing so that you can scale with confidence and reduce time to market? Are you sick of feeling overwhelmed by the complexity and guesswork of biologics drug development? Do you wish you had more time to enjoy the beauty of science, without worrying about failing your cell culture process development and commerc ...
…
continue reading
Between the Biotech Waves—discussing recent developments and market dynamics impacting the biotech sector.
…
continue reading
Illuminating life science career opportunities outside of academia through the experiences of those who have been there before.
…
continue reading
A weekly audio digest of the most important news in drug development affecting the pharmaceutical and biotech industry
…
continue reading
Back of the Napkin is a podcast series from Bio-Techne that meets scientific pioneers. It goes beyond the publications to hear the untold stories from innovation corner, where ideas and discoveries are conceived.
…
continue reading
Horizon 3 is a biotech fund which has been formed to help investors to have a real impact on a range of global health challenges through new bio technologies, aiming to de-risk the investment risks inherent in such a technical area.These podcasts are a series aimed at educating investors on the issues, risks and opportunities involved in investing ion the biotech sector.
…
continue reading
In einer Podcast Folge wird jeweils ein Punkt einer Lernplaneinheit vorgestellt. Viele sind One-Taker meiner eigenen Biotech-Abi Vorbereitung :D Cover art photo provided by Annie Spratt on Unsplash: https://unsplash.com/@anniespratt
…
continue reading
Biotechnology for Tomorrow
…
continue reading
The Biotech Futurist aims to foster deep understanding and discussion about exciting hot topics in biotech at the intersection with artificial intelligence and medicine, exploring CRISPR therapeutics, neuroscience, genetic diseases, interventional genomics, machine learning in biology, behavior, neuroscience, omics, cellular recording, liquid biopsy, oncology, longevity, and more. Your host Luca Fusar Bassini, PhD student at EPFL in Switzerland, interviews an expert guest every week.
…
continue reading
A weekly live audience show featuring the people building and funding companies that are extending healthy human lifespan. Join us Thursdays on Clubhouse and check the show schedule on longevitybiotechshow.com Hosted by Nathan Cheng (founder @ Longevity Marketcap // Longevity List) and Robert Ziman (Cohen Lab).
…
continue reading
From sales to medical affairs, we will help you break into and navigate your career in the biopharma industry!
…
continue reading
Explore the world of cloning, protein folding, genome mapping, and more with the most important researchers in the field. Although the show is no longer in production at TWiT, you can enjoy episodes from the TWiT Archives.
…
continue reading
Explore the world of cloning, protein folding, genome mapping, and more with the most important researchers in the field. Although the show is no longer in production at TWiT, you can enjoy episodes from the TWiT Archives.
…
continue reading
Encode Ideas authors research on publicly traded micro / small cap healthcare (biotech & medtech) companies. The Plainspoken podcast is an extension of our research, where we will interview executives from micro / small cap health care companies, portfolio managers who invest in micro / small cap healthcare, and key opinion leaders who can offer insights into therapeutics areas of interest to investors. The podcast is for entertainment purposes only and should not be considered financial adv ...
…
continue reading
What happens when robots, AI, and big data enter the hospital? Glenn Cohen (a professor and deputy dean at Harvard Law School) is unpacking that question in this exploration of biotechnology, ethics, medical law, and health care policy. Each week, he’ll interrogate a single technology – such as digital pills, AI-powered decision support algorithms, or digital health apps – through the lens of ethical concerns like informed consent, liability, and privacy.
…
continue reading
Interviews with the researchers, founders, and investors of the BioTech industry. An insiders look into what is going on in the world of BioTech, from curing aging to psychedelic therapy, we interview the game changers of the industry. The unsung hero's that are moving the industry forward in a significant way. The world is going to be a vastly different place in the next 10-20 years because of what's happening in the BioTech industry right now.Human civilization will move forward farther, f ...
…
continue reading
1
🧬Michael Chen - Nuclera - Part 2 | From Grad Student to Biotech CEO | Unique Challenges Combining Science & Business | Developing Breakthrough Products | Building Partnerships with Big Pharma | Creating ...
1:04:31
1:04:31
Spela senare
Spela senare
Listor
Gilla
Gillad
1:04:31
The Biotech Startups Podcast is brought to you by Excedr. Excedr provides life science startups with equipment leases on founder-friendly terms to accelerate R&D and commercialization. Know anyone that needs lab equipment? Join Excedr’s referral program: Give Your Friends $1,000, and Earn $1,000 for Each Qualified Referral 💸. Get your unique referr…
…
continue reading
1
Pharma and Biotech Daily: Analyzing the Impact of Trump's Win on the Industry
0:55
0:55
Spela senare
Spela senare
Listor
Gilla
Gillad
0:55
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Analysts are expressing mixed reactions to Donald Trump's election victory. There are potential positives for the biopharma industry, such as a more friendly FTC for M&A deals. However, concerns have been raised about what…
…
continue reading
1
104: One-Stop Shop vs. Specialist CDMO: A Scientist's Guide to CDMO Selection with Sigma Mostafa - Part 2
17:17
17:17
Spela senare
Spela senare
Listor
Gilla
Gillad
17:17
Send us a text Want to peek behind the curtain of a leading Contract Development and Manufacturing Organization (CDMO)? In this inspiring episode, KBI Biopharma's Chief Scientific Officer Sigma Mostafa reveals the intricate world of bioprocess development and manufacturing. Sigma shares game-changing insights into accelerating biologics development…
…
continue reading
1
CRISPR Dilemma... Dr. Eben Kirksey, Anthropologist & Author, “The Mutant Project: Inside the Global Race to Genetically Modify Humans”
38:02
38:02
Spela senare
Spela senare
Listor
Gilla
Gillad
38:02
This week on BioTech Nation, we talk with Dr. Eben Kirksey about the ethical issues behind CRISPR, the gene-editing tool that made headlines with the birth of the first “CRISPR babies” in China. Dr. Kirksey shares his experiences investigating this controversial experiment and highlights the deeper questions it raises. He stresses the importance of…
…
continue reading
1
Rob Williamson, CEO of Triumvira, on Biotech’s High-Stakes Path and Cell Therapy Innovations
23:45
23:45
Spela senare
Spela senare
Listor
Gilla
Gillad
23:45
Synopsis: Rob Williamson, CEO of Triumvira, joins Biotech 2050 host, Rahul Chaturvedi, to discuss his dynamic career from economics to biotech, tackling the volatile capital markets, and navigating high-stakes decisions in cell therapy. He shares insights on therapeutic developments in cell therapy, the pressures of solid tumor research, and the ev…
…
continue reading
1
The New Board Game: Strategic Moves in Biotech
16:43
16:43
Spela senare
Spela senare
Listor
Gilla
Gillad
16:43
The relationship between biotech leadership and their boards is evolving, particularly as private equity takes a larger role in the industry. In this episode of the Emerging Biotech Leader, Nick Amigone from Amulet Capital Partners offers a unique perspective on building effective board relationships from the private equity vantage point. The conve…
…
continue reading
1
An Unanticipated Biotech Startup With OS Therapies' Paul Romness
49:12
49:12
Spela senare
Spela senare
Listor
Gilla
Gillad
49:12
We love to hear from our listeners. Send us a message. Becoming a biotech CEO wasn't on Paul Romness' bingo card. He'd forged his place in the biopharma industry as a foremost public and policy affairs expert. Thirteen years at J&J, more than 5 at Amgen, and half a dozen at Boehringer Ingelheim had earned him the right to coast into a consulting gi…
…
continue reading
1
101. Biotech's Glow Up: How Estée Lauder is Leveling Up Skincare with Rocky Graziose
1:00:16
1:00:16
Spela senare
Spela senare
Listor
Gilla
Gillad
1:00:16
Rocky Graziose from Estée Lauder is here to discuss the innovative intersection of biotechnology and beauty. With a background in plant natural products chemistry, Rocky brings an insider perspective on how Estée Lauder is pushing boundaries in skincare and cosmetics. He talks about the evolution of the beauty industry and how Estée Lauder’s commit…
…
continue reading
Sitryx Therapeutics is a private UK biopharma company founded in 2018. It is a leader in the field of immunometabolism, an area of immunology that looks to rebalance the immune system to achieve sustained disease remission in autoimmune and inflammatory diseases. Sitryx already has big pharma validation following a deal with Eli Lilly in 2020 worth…
…
continue reading
1
How Tech Is Solving The Organ Shortage Problem with Shola Oyewole
35:39
35:39
Spela senare
Spela senare
Listor
Gilla
Gillad
35:39
The organ shortage crisis is one of modern medicine's greatest challenges, but innovative technologies like 3D printing and AI are changing the game. Please visit our website to get more information: https://swangroup.net/ In this episode, I talk with Shola Oyewole, VP of Digital Innovation at United Therapeutics, to explore how they lead the charg…
…
continue reading
1
From Moderna to Dash Bio - Revolutionizing Drug Development with Dave Johnson
32:54
32:54
Spela senare
Spela senare
Listor
Gilla
Gillad
32:54
In this episode of Data in Biotech, Ross Katz sits down with Dave Johnson, CEO and co-founder of Dash Bio, a next-gen drug development services company with a mission to revolutionize clinical bioanalysis and streamline drug development. Dave begins the episode by taking us back to the early research days in Moderna, where he helped lay the groundw…
…
continue reading
Ben Wiener is the founder and managing partner of JumpSpeed, the first and only venture capital fund dedicated to investing in early-stage startups in Jerusalem.Avraham sat down with Ben in the offices of JMB Davis Ben-David in Jerusalem to discuss why Ben started Jumpspeed, what he learned from investing in day one startups, his successes and fail…
…
continue reading
1
Trees that Survive Citrus Greening - Gary England
50:50
50:50
Spela senare
Spela senare
Listor
Gilla
Gillad
50:50
Citrus greening disease or HLB has severely impacted Florida citrus production. And while many solutions have been proposed, there is interest in a number of trees that have shown to not show symptoms of the disease. This week's episode discusses the disease with retired extension specialist Gary England as he evaluates "survivor" trees. These tree…
…
continue reading
1
10 Resume Mistakes That Might Cost You Your Dream Job
21:49
21:49
Spela senare
Spela senare
Listor
Gilla
Gillad
21:49
In this episode, I explore 10 common resume mistakes that might be hindering your biotech job search. Drawing from my recent BioSpace column and observations, I offer practical advice on pitfalls to avoid, such as using profile pictures, fancy formatting, and not proofreading. I emphasize the importance of a professional email address and discuss t…
…
continue reading
1
Navigating Startups and Shaping Industry Breakthroughs with Sarah Ives from TripleBar
55:55
55:55
Spela senare
Spela senare
Listor
Gilla
Gillad
55:55
In this episode, we follow the inspiring journey of Sarah Ives, Vice President of BioPharma at TripleBar, as she shares her transition from a hands-on scientist to an influential leader in biotech. Sarah shares her journey, starting with her early work in bioassay development and biosensing, and candidly discusses the challenges she faced as she mo…
…
continue reading
1
Small Offerings, Big Impact: Demystifying Micro-IPOs in Biotech with David Sans, Head of Healthcare Investment Banking at EF Hutton
37:13
37:13
Spela senare
Spela senare
Listor
Gilla
Gillad
37:13
This week, I had an insightful conversation with David Sans, PhD, FAARM, MBA, who heads healthcare investment banking at EF Hutton. We discussed the intricacies of different Public Offering strategies, including micro IPOs, which offer a unique avenue for biotech companies. David provides a deep perspective on the strategic implications of IPOs for…
…
continue reading
1
From Code to Crops: Roots co-founder Abhi's Cutting-Edge Use of AI in Agriculture
1:04:30
1:04:30
Spela senare
Spela senare
Listor
Gilla
Gillad
1:04:30
One of the most exciting conversations I have had all year. Abhi, co-founder and CEO of roots is is a software engineer turned farmer who is really pushing LLMs to the edge of their abilities. In this interview, we discover how he has been using Google Gemini’s large context windows to feed it thousands of agriculture science papers and discover in…
…
continue reading
1
The Importance of Mastering Change as a Biotech Leader ft. Dan Couto
55:01
55:01
Spela senare
Spela senare
Listor
Gilla
Gillad
55:01
In this episode of the Phase 3 Biotech Leadership Podcast, we sit down with Dan Couto, Chief Operating Officer of Vedanta Biosciences, to explore the critical role of mastering change in biotech leadership. Dan shares his diverse experiences across the biotech sector, highlighting key leadership skills such as problem-solving, effective communicati…
…
continue reading